A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study
Condition: Graves' Orbitopathy Interventions: Drug: Atorvastatin 20mg; Other: Placebo Sponsors: University of Pisa; Università degli Studi dell'Insubria; University of Catania; University of Messina Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Clinical Trials | Lipitor | Research | Statin Therapy | Study | Zivast